Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Aimmune Therapeutics
Aimmune to Submit FDA Application for Peanut OIT Candidate by End...
Dave Bloom
-
2018/03/06
If approved, AR101 could be offered as the first FDA approved OIT therapy for peanut allergy.
Results of Phase III Trial of Aimmune's Peanut OIT Therapy
Dave Bloom
-
2018/02/20
After one year, 3/4 of patients ages 4-17 who received the therapy were able to consume a minimum of 300mg of peanut. Results for adults were less clear.
Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate
Dave Bloom
-
2018/01/08
The company announces their timeline for continued progress toward an FDA approved standardized therapy.
Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy
Dave Bloom
-
2017/10/19
More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.
Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...
Dave Bloom
-
2017/05/17
First of 440 patients enrolled in study of AR101.
Breakthrough Food Allergy Therapies and the Big Business Behind Them
Dave Bloom
-
2015/10/28
What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.
1
2
3
4
Page 4 of 4